Sarah Holoubek

Most large healthcare companies will have numerous teams - innovation teams, maybe a venture fund, business units - all doing different things. How much more powerful would it be if everyone agreed on a common investment thesis? We know our business model is changing and, therefore, where is our big bet?
— Sarah Holoubek

She’s staged a number of open innovation challenges in health tech and is here to give advice to the ‘healthcare establishment’ on what works and what doesn’t. Sarah Holoubek, CEO of Luminary Labs, has an impeccable track record for bridging the gap between big healthcare systems, pharma companies, and health plans – and the startups they need to bring agility to the way they solve their business problems and enter new markets. How can these organizations best stage open innovation challenges, combat ‘pilot fatigue,’ and avoid scattershot investing? Listen in for her tips.